Hompland I, Boye K, Wiedswang AM, Papakonstantinou A, Røsok B, Joensuu H, Bruland Ø(2024) Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study Acta Oncol, 63, 288-293 DOI 10.2340/1651-226X.2024.39851, PubMed 38712513
Machak GN, Bruland ØS, Romanova TN, Kovalev AV(2024) Denosumab induction and Zoledronic acid maintenance therapy for recurrent unresectable giant cell tumour of the distal tibia: A case report with sustained tumour control after drug withdrawal J Bone Oncol, 45, 100596 DOI 10.1016/j.jbo.2024.100596, PubMed 38545297
Bruland ØS, Larsen RH, Baum RP, Juzeniene A(2023) Editorial: Targeted alpha particle therapy in oncology Front Med (Lausanne), 10, 1165747 DOI 10.3389/fmed.2023.1165747, PubMed 36960341